Abstract
Tumor cells are surrounded by infiltrating inflammatory cells, such as lymphocytes, neutrophils, macrophages, and mast cells. A body of evidence indicates that mast cells are associated with various types of tumors. Although role of mast cells can be directly related to their granule content, their function in angiogenesis and tumor progression remains obscure. This study aims to understand the role of mast cells in these processes. Tumors were chemically induced in BALB/c mice and tumor progression was divided into Phases I, II and III. Phase I tumors exhibited a large number of mast cells, which increased in phase II and remained unchanged in phase III. The expression of mouse mast cell protease (mMCP)-4, mMCP-5, mMCP-6, mMCP-7, and carboxypeptidase A were analyzed at the 3 stages. Our results show that with the exception of mMCP-4 expression of these mast cell chymase (mMCP-5), tryptases (mMCP-6 and 7), and carboxypeptidase A (mMC-CPA) increased during tumor progression. Chymase and tryptase activity increased at all stages of tumor progression whereas the number of mast cells remained constant from phase II to III. The number of new blood vessels increased significantly in phase I, while in phases II and III an enlargement of existing blood vessels occurred. In vitro, mMCP-6 and 7 are able to induce vessel formation. The present study suggests that mast cells are involved in induction of angiogenesis in the early stages of tumor development and in modulating blood vessel growth in the later stages of tumor progression.
Highlights
Mast cells are gaining increased recognition as immunomodulators playing a role in a wide variety of physiological processes [1,2]
One major route by which mast cells could affect various pathways, including angiogenesis is through the effects of mediators such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), IL-8, metalloproteases, serine proteases among others [17,18,19,20] that are stored within the mast cell secretory granules and released upon mast cell activation [1,21,22]
The present study shows that the expression of mast cell chymase and tryptase subtypes as well as carboxypeptidase A varies during tumor progression
Summary
Mast cells are gaining increased recognition as immunomodulators playing a role in a wide variety of physiological processes [1,2]. One major route by which mast cells could affect various pathways, including angiogenesis is through the effects of mediators such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), IL-8, metalloproteases, serine proteases among others [17,18,19,20] that are stored within the mast cell secretory granules and released upon mast cell activation [1,21,22] These mediators are not specific to mast cells and are expressed by other cell types involved in tumor progression. Previous studies on the role of mast cells in tumorigenesis failed to analyze maturation of mast cell associated with the tumor
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
